To explore whether reducing Aβ generation ameliorates BBB impairment, we treated ReN‐AD cells with BACE1 inhibitor (LY2886721), which prevents the production of Aβ by blocking the β‐secretase enzyme. This evidence concerns the gene BACE1 and Alzheimer disease.